Current evidence suggests phyto-oestrogens are safe and well tolerated by postmenopausal women, with moderately increased risk of adverse gastrointestinal effects compared with placebo

Evidence-Based Medicine

Volumn 15, Issue 2, 2010, Pages 55-56

  Maskarinec, Gertraud ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HERBACEOUS AGENT; ISOFLAVONE; PHYTOESTROGEN; PLACEBO; SOYBEAN PROTEIN;

BONE DENSITY; CARDIOVASCULAR RISK; CIMICIFUGA RACEMOSA; COGNITION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; LINSEED; MAJOR CLINICAL STUDY; NOTE; POSTMENOPAUSE; RED CLOVER; SOYBEAN; SYMPTOM; SYSTEMATIC REVIEW;

EID: 77951834351     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm1055     Document Type: Note

References (9)

1. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry 2004;65:995-1016.
2. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002;3:364-373
3. Cassidy A. Dietary phyto-oestrogens: molecular mechanisms, bioavailability and importance to menopausal health. Nutr Res Rev 2005;18:183-201. (Pubitemid 43132201)
4. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001;131:3095S-108S.
5. Barnes S. Soy isoflavones - phytoestrogens and what else? J Nutr 2004;134:1225S-8S.
6. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 2006;55:1-12. (Pubitemid 44477039)
7. Tempfer CB, Bentz EK, Leodolter S, et al. Phytoestrogens in clinical practice: a review of the literature. Fertil Steril 2007;87:1243-1249 (Pubitemid 46829161)
8. Shu XO, Zheng Y, Cai H, et al. Soy food intake and breast cancer survival. JAMA 2009;302:2437-2443
9. Wu AH, Yu MC, Tseng CC, et al. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.